Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 321

    1.

    Microalbuminuria, preeclampsia and preterm delivery in pregnant women with type 1 diabetes - results from a nation-wide Danish study.

    Jensen DM, Damm P, Ovesen P, Mølsted-Pedersen L, Beck-Nielsen H, Westergaard JG, Moeller M, Mathiesen ER.

    Diabetes Care. 2009 Oct 21. [Epub ahead of print]PMID: 19846800 [PubMed - as supplied by publisher]Related articles

    2.

    Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus: Prevalence and Association with Myocardial and Vascular Disease.

    Poulsen MK, Henriksen JE, Dahl J, Johansen A, Gerke O, Vach W, Haghfelt T, Høilund-Carlsen PF, Beck-Nielsen H, Møller JE.

    Circ Cardiovasc Imaging. 2009 Oct 21. [Epub ahead of print]PMID: 19846730 [PubMed - as supplied by publisher]Related articles

    3.

    Dysregulation of glycogen synthase COOH- and NH2-terminal phosphorylation by insulin in obesity and type 2 diabetes mellitus.

    Højlund K, Birk JB, Klein DK, Levin K, Rose AJ, Hansen BF, Nielsen JN, Beck-Nielsen H, Wojtaszewski JF.

    J Clin Endocrinol Metab. 2009 Nov;94(11):4547-56. Epub 2009 Oct 16.PMID: 19837931 [PubMed - in process]Related articles

    4.

    Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients.

    Poulsen MK, Henriksen JE, Dahl J, Johansen A, Møller JE, Gerke O, Vach W, Haghfelt T, Beck-Nielsen H, Høilund-Carlsen PF.

    J Nucl Cardiol. 2009 Nov-Dec;16(6):878-87. Epub 2009 Aug 14.PMID: 19685102 [PubMed - in process]Related articles

    5.

    Evidence-based insulin treatment in type 1 diabetes mellitus.

    Jacobsen IB, Henriksen JE, Hother-Nielsen O, Vach W, Beck-Nielsen H.

    Diabetes Res Clin Pract. 2009 Oct;86(1):1-10. Epub 2009 Aug 3.PMID: 19647887 [PubMed - in process]Related articles

    6.

    A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.

    Henriksen K, Byrjalsen I, Nielsen RH, Madsen AN, Larsen LK, Christiansen C, Beck-Nielsen H, Karsdal MA.

    Eur J Pharmacol. 2009 Aug 15;616(1-3):340-5. Epub 2009 Jul 10.PMID: 19595686 [PubMed - indexed for MEDLINE]Related articles

    7.

    Maximal lipid oxidation in patients with type 2 diabetes is normal and shows an adequate increase in response to aerobic training.

    Mogensen M, Vind BF, Højlund K, Beck-Nielsen H, Sahlin K.

    Diabetes Obes Metab. 2009 Sep;11(9):874-83. Epub 2009 Jun 16.PMID: 19531056 [PubMed - in process]Related articles

    8.

    Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

    Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Team.

    Lancet. 2009 Jun 20;373(9681):2125-35. Epub 2009 Jun 6.PMID: 19501900 [PubMed - indexed for MEDLINE]Related articles

    9.

    The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control.

    Jacobsen IB, Henriksen JE, Beck-Nielsen H.

    Basic Clin Pharmacol Toxicol. 2009 Sep;105(3):145-9. Epub 2009 May 26.PMID: 19496776 [PubMed - indexed for MEDLINE]Related articles

    10.

    Increased risk of type 2 diabetes in elderly twins.

    Poulsen P, Grunnet LG, Pilgaard K, Storgaard H, Alibegovic A, Sonne MP, Carstensen B, Beck-Nielsen H, Vaag A.

    Diabetes. 2009 Jun;58(6):1350-5. Epub 2009 Mar 31.PMID: 19336677 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes.

    Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Moelsted-Pedersen L, Westergaard JG, Moeller M, Damm P.

    Diabetes Care. 2009 Jun;32(6):1046-8. Epub 2009 Mar 5.PMID: 19265024 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [Weight history of patients with newly diagnosed type 2 diabetes--secondary publication]

    de Fine Olivarius N, Richelsen B, Siersma V, Andreasen AH, Beck-Nielsen H.

    Ugeskr Laeger. 2008 Nov 3;170(45):3640-3. Danish. PMID: 18988367 [PubMed - indexed for MEDLINE]Related articles

    13.

    Weight history of patients with newly diagnosed Type 2 diabetes.

    de Fine Olivarius N, Richelsen B, Siersma V, Andreasen AH, Beck-Nielsen H.

    Diabet Med. 2008 Aug;25(8):933-41.PMID: 18959606 [PubMed - indexed for MEDLINE]Related articles

    14.

    Mitochondrial dysfunction in type 2 diabetes and obesity.

    Højlund K, Mogensen M, Sahlin K, Beck-Nielsen H.

    Endocrinol Metab Clin North Am. 2008 Sep;37(3):713-31, x. Review.PMID: 18775360 [PubMed - indexed for MEDLINE]Related articles

    15.

    Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes.

    Frederiksen CM, Højlund K, Hansen L, Oakeley EJ, Hemmings B, Abdallah BM, Brusgaard K, Beck-Nielsen H, Gaster M.

    Diabetologia. 2008 Nov;51(11):2068-77. Epub 2008 Aug 22.PMID: 18719883 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.

    Skov V, Glintborg D, Knudsen S, Tan Q, Jensen T, Kruse TA, Beck-Nielsen H, Højlund K.

    PLoS One. 2008 Jun 18;3(6):e2466.PMID: 18560589 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

    Glintborg D, Højlund K, Andersen NR, Hansen BF, Beck-Nielsen H, Wojtaszewski JF.

    J Clin Endocrinol Metab. 2008 Sep;93(9):3618-26. Epub 2008 Jun 10.PMID: 18544618 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).

    Komajda M, Curtis P, Hanefeld M, Beck-Nielsen H, Pocock SJ, Zambanini A, Jones NP, Gomis R, Home PD; RECORD Study Group.

    Cardiovasc Diabetol. 2008 Apr 24;7:10.PMID: 18435852 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives.

    Hulstrøm V, Højlund K, Vinten J, Beck-Nielsen H, Levin K.

    Diabetes Obes Metab. 2008 Nov;10(11):1019-28. Epub 2008 Feb 18.PMID: 18284435 [PubMed - indexed for MEDLINE]Related articles

    20.

    Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes?

    Højlund K, Beck-Nielsen H.

    Curr Diabetes Rev. 2006 Nov;2(4):375-95. Review.PMID: 18220643 [PubMed - indexed for MEDLINE]Related articles

    21.

    Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks.

    Christesen HB, Brusgaard K, Beck Nielsen H, Brock Jacobsen B.

    Clin Endocrinol (Oxf). 2008 May;68(5):747-55. Epub 2008 Jan 15. Erratum in: Clin Endocrinol (Oxf). 2008 Jun;68(6):1011. PMID: 18208578 [PubMed - indexed for MEDLINE]Related articles

    22.

    Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose?

    Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Mølsted-Pedersen L, Damm P.

    Acta Obstet Gynecol Scand. 2008;87(1):59-62.PMID: 18158628 [PubMed - indexed for MEDLINE]Related articles

    23.

    Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H.

    Evid Based Med. 2007 Dec;12(6):170. No abstract available. PMID: 18063730 [PubMed]Related articles

    24.

    Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.

    Glintborg D, Højlund K, Andersen M, Henriksen JE, Beck-Nielsen H, Handberg A.

    Diabetes Care. 2008 Feb;31(2):328-34. Epub 2007 Nov 13.PMID: 18000176 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

    Højlund K, Glintborg D, Andersen NR, Birk JB, Treebak JT, Frøsig C, Beck-Nielsen H, Wojtaszewski JF.

    Diabetes. 2008 Feb;57(2):357-66. Epub 2007 Oct 31.PMID: 17977950 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Low birth weight and zygosity status is associated with defective muscle glycogen and glycogen synthase regulation in elderly twins.

    Poulsen P, Wojtaszewski JF, Richter EA, Beck-Nielsen H, Vaag A.

    Diabetes. 2007 Nov;56(11):2710-4. Epub 2007 Aug 13.PMID: 17698598 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.

    Skov V, Glintborg D, Knudsen S, Jensen T, Kruse TA, Tan Q, Brusgaard K, Beck-Nielsen H, Højlund K.

    Diabetes. 2007 Sep;56(9):2349-55. Epub 2007 Jun 11.PMID: 17563058 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Group.

    N Engl J Med. 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.PMID: 17551159 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Rosiglitazone RECORD study: glucose control outcomes at 18 months.

    Home PD, Jones NP, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Komajda M, Curtis P; RECORD Study Group.

    Diabet Med. 2007 Jun;24(6):626-34.PMID: 17517066 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Insulin resistance, insulin response, and obesity as indicators of metabolic risk.

    Ferrannini E, Balkau B, Coppack SW, Dekker JM, Mari A, Nolan J, Walker M, Natali A, Beck-Nielsen H; RISC Investigators.

    J Clin Endocrinol Metab. 2007 Aug;92(8):2885-92. Epub 2007 May 15.PMID: 17504904 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes.

    Mogensen M, Sahlin K, Fernström M, Glintborg D, Vind BF, Beck-Nielsen H, Højlund K.

    Diabetes. 2007 Jun;56(6):1592-9. Epub 2007 Mar 9.PMID: 17351150 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Counting drugs to understand the disease: the case of measuring the diabetes epidemic.

    Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W.

    Popul Health Metr. 2007 Feb 21;5:2.PMID: 17313683 [PubMed]Related articlesFree article

    33.

    Hepatic autoregulation: response of glucose production and gluconeogenesis to increased glycogenolysis.

    Staehr P, Hother-Nielsen O, Beck-Nielsen H, Roden M, Stingl H, Holst JJ, Jones PK, Chandramouli V, Landau BR.

    Am J Physiol Endocrinol Metab. 2007 May;292(5):E1265-9. Epub 2007 Jan 9.PMID: 17213474 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    [Weight changes and the effect of anti-diabetes treatment in the first 5 years after diabetes diagnosis - secondary publication]

    de Fine Olivarius N, Andreasen AH, Siersma V, Richelsen B, Beck-Nielsen H.

    Ugeskr Laeger. 2006 Nov 6;168(45):3913-6. Danish. PMID: 17118255 [PubMed]Related articles

    35.

    Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance.

    Handberg A, Levin K, Højlund K, Beck-Nielsen H.

    Circulation. 2006 Sep 12;114(11):1169-76. Epub 2006 Sep 4.PMID: 16952981 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus.

    de Fine Olivarius N, Andreasen AH, Siersma V, Richelsen B, Beck-Nielsen H.

    Diabetologia. 2006 Sep;49(9):2058-67. Epub 2006 Jul 14.PMID: 16841232 [PubMed - indexed for MEDLINE]Related articles

    37.

    Long-chain Acyl-CoA is not primarily increased in myotubes established from type 2 diabetic subjects.

    Just M, Faergeman NJ, Knudsen J, Beck-Nielsen H, Gaster M.

    Biochim Biophys Acta. 2006 Jul;1762(7):666-72. Epub 2006 May 23.PMID: 16815692 [PubMed - indexed for MEDLINE]Related articles

    38.

    Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.

    Glintborg D, Hermann AP, Andersen M, Hagen C, Beck-Nielsen H, Veldhuis JD, Henriksen JE.

    Fertil Steril. 2006 Aug;86(2):385-97. Epub 2006 Jun 16.PMID: 16782094 [PubMed - indexed for MEDLINE]Related articles

    39.

    Partial rescue of in vivo insulin signalling in skeletal muscle by impaired insulin clearance in heterozygous carriers of a mutation in the insulin receptor gene.

    Højlund K, Wojtaszewski JF, Birk J, Hansen BF, Vestergaard H, Beck-Nielsen H.

    Diabetologia. 2006 Aug;49(8):1827-37. Epub 2006 Jun 8.PMID: 16761106 [PubMed - indexed for MEDLINE]Related articles

    40.

    Energy expenditure, body composition and insulin response to glucose in male twins discordant for the Trp64Arg polymorphism of the beta3-adrenergic receptor gene.

    Højlund K, Christiansen C, Bjørnsbo KS, Poulsen P, Bathum L, Henriksen JE, Lammert O, Beck-Nielsen H.

    Diabetes Obes Metab. 2006 May;8(3):322-30.PMID: 16634992 [PubMed - indexed for MEDLINE]Related articles

    41.

    Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes.

    Højlund K, Frystyk J, Levin K, Flyvbjerg A, Wojtaszewski JF, Beck-Nielsen H.

    Diabetologia. 2006 Jun;49(6):1283-91. Epub 2006 Apr 12.PMID: 16609880 [PubMed - indexed for MEDLINE]Related articles

    42.

    Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects.

    Gaster M, Beck-Nielsen H.

    Biochim Biophys Acta. 2006 Jan;1761(1):100-10. Epub 2006 Jan 18.PMID: 16442843 [PubMed - indexed for MEDLINE]Related articles

    43.

    Total and regional fat distribution is strongly influenced by genetic factors in young and elderly twins.

    Malis C, Rasmussen EL, Poulsen P, Petersen I, Christensen K, Beck-Nielsen H, Astrup A, Vaag AA.

    Obes Res. 2005 Dec;13(12):2139-45.PMID: 16421348 [PubMed - indexed for MEDLINE]Related articles

    44.

    Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.

    Abdallah BM, Beck-Nielsen H, Gaster M.

    Eur J Clin Invest. 2005 Oct;35(10):627-34.PMID: 16178882 [PubMed - indexed for MEDLINE]Related articles

    45.

    Patients with Type 2 diabetes and ischaemic heart disease have similar coronary flow reserve and endothelial function compared with non-diabetic patients with ischaemic heart disease.

    Hoffmann SK, Jensen LO, Thayssen P, Henriksen JE, Beck-Nielsen H, Haghfelt T.

    Diabet Med. 2005 Oct;22(10):1454-5. No abstract available. PMID: 16176213 [PubMed - indexed for MEDLINE]Related articles

    46.

    Gestational weight gain and pregnancy outcomes in 481 obese glucose-tolerant women.

    Jensen DM, Ovesen P, Beck-Nielsen H, Mølsted-Pedersen L, Sørensen B, Vinter C, Damm P.

    Diabetes Care. 2005 Sep;28(9):2118-22.PMID: 16123476 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Dargie H, Komajda M, Gubb J, Biswas N, Jones NP.

    Diabetologia. 2005 Sep;48(9):1726-35. Epub 2005 Jul 16.PMID: 16025252 [PubMed - indexed for MEDLINE]Related articles

    48.

    The epidemic of type 2 diabetes is a statistical artefact.

    Green A, Støvring H, Andersen M, Beck-Nielsen H.

    Diabetologia. 2005 Aug;48(8):1456-8. Epub 2005 Jun 30. No abstract available. PMID: 15988576 [PubMed - indexed for MEDLINE]Related articles

    49.

    Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.

    Ortenblad N, Mogensen M, Petersen I, Højlund K, Levin K, Sahlin K, Beck-Nielsen H, Gaster M.

    Biochim Biophys Acta. 2005 Jun 30;1741(1-2):206-14. Epub 2005 Apr 22.PMID: 15894466 [PubMed - indexed for MEDLINE]Related articles

    50.

    OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.

    Field LL, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen TB, Beck-Nielsen H.

    Diabetes. 2005 May;54(5):1588-91.PMID: 15855350 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...